Profile | GDS2987 / GI_42661209-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 0.3 | 1 |
GSM215244 | HMVEC_vehicle_rep2 | ||
GSM215253 | HMVEC_vehicle_rep3 | ||
GSM215254 | HMVEC_atorvastatin_rep1 | ||
GSM215282 | HMVEC_atorvastatin_rep3 | 6.7 | 16 |
GSM215344 | HMVEC_atorvastatin_rep2 | ||
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | ||
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | ||
GSM215295 | HMVEC_SLx2119_rep2 | 20 | 38 |
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | 2756.8 | 97 |
GSM215298 | PASMC_vehicle_rep2 | 2445.2 | 97 |
GSM215310 | PASMC_vehicle_rep3 | 2451.3 | 97 |
GSM215311 | PASMC_atorvastatin_rep1 | 2489.5 | 97 |
GSM215312 | PASMC_atorvastatin_rep2 | 2870.7 | 98 |
GSM215313 | PASMC_atorvastatin_rep3 | 3267.7 | 98 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 1819.3 | 96 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 2114.2 | 97 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 1806.1 | 96 |
GSM215327 | PASMC_SLx2119_rep1 | 240.6 | 83 |
GSM215328 | PASMC_SLx2119_rep2 | 152.7 | 79 |
GSM215329 | PASMC_SLx2119_rep3 | 249.9 | 83 |
GSM215330 | Fibroblasts_vehicle_rep1 | 610.1 | 91 |
GSM215331 | Fibroblasts_vehicle_rep2 | 702.8 | 92 |
GSM215332 | Fibroblasts_vehicle_rep3 | 632.9 | 92 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 705.3 | 92 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 725.4 | 92 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 661.1 | 92 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 714.6 | 92 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 629.1 | 92 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 676.6 | 92 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 223.7 | 82 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 252.9 | 84 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 228.1 | 83 |